Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.

<h4>Introduction</h4>Little is known about medication use among women with eating disorders in relation to pregnancy.<h4>Aims</h4>To explore patterns of and associations between use of psychotropic, gastrointestinal and analgesic medications and eating disorders in the period...

Full description

Saved in:
Bibliographic Details
Main Authors: Angela Lupattelli, Olav Spigset, Leila Torgersen, Stephanie Zerwas, Marianne Hatle, Ted Reichborn-Kjennerud, Cynthia M Bulik, Hedvig Nordeng
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0133045
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850161534734434304
author Angela Lupattelli
Olav Spigset
Leila Torgersen
Stephanie Zerwas
Marianne Hatle
Ted Reichborn-Kjennerud
Cynthia M Bulik
Hedvig Nordeng
author_facet Angela Lupattelli
Olav Spigset
Leila Torgersen
Stephanie Zerwas
Marianne Hatle
Ted Reichborn-Kjennerud
Cynthia M Bulik
Hedvig Nordeng
author_sort Angela Lupattelli
collection DOAJ
description <h4>Introduction</h4>Little is known about medication use among women with eating disorders in relation to pregnancy.<h4>Aims</h4>To explore patterns of and associations between use of psychotropic, gastrointestinal and analgesic medications and eating disorders in the period before, during and after pregnancy.<h4>Method</h4>This study is based on the Norwegian Mother and Child Cohort Study (MoBa). A total of 62,019 women, enrolled at approximately 17 weeks' gestation, had valid data from the Norwegian Medical Birth Registry and completed three MoBa questionnaires. The questionnaires provided diagnostic information on broadly defined anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED) and recurrent self-induced purging in the absence of binge eating (EDNOS-P), along with self-reported use of medication six months before, during, and 0-6 months after pregnancy.<h4>Results</h4>The prevalence of eating disorder subtypes before and/or during pregnancy was: 0.09% AN (n = 54), 0.94% BN (n = 585), 0.10% EDNOS-P (n = 61) and 5.00% BED (n = 3104). The highest over-time prevalence of psychotropic use was within the AN (3.7-22.2%) and EDNOS-P (3.3-9.8%) groups. Compared to controls, BN was directly associated with incident use of psychotropics in pregnancy (adjusted RR: 2.25, 99% CI: 1.17-4.32). Having AN (adjusted RR: 5.11, 99% CI: 1.53-17.01) or EDNOS-P (adjusted RR: 6.77, 99% CI: 1.41-32.53) was directly associated with use of anxiolytics/sedatives postpartum. The estimates of use of analgesics (BED) and laxatives (all eating disorders subtypes) were high at all time periods investigated.<h4>Conclusions</h4>Use of psychotropic, gastrointestinal, and analgesic medications is extensive among women with eating disorders in the period around pregnancy. Female patients with eating disorders should receive evidence-based counseling about the risk of medication exposure versus the risk of untreated psychiatric illness during pregnancy and postpartum.
format Article
id doaj-art-01ab9fc3744a4cb287cb9c20e16fda48
institution OA Journals
issn 1932-6203
language English
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-01ab9fc3744a4cb287cb9c20e16fda482025-08-20T02:22:49ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-01107e013304510.1371/journal.pone.0133045Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.Angela LupattelliOlav SpigsetLeila TorgersenStephanie ZerwasMarianne HatleTed Reichborn-KjennerudCynthia M BulikHedvig Nordeng<h4>Introduction</h4>Little is known about medication use among women with eating disorders in relation to pregnancy.<h4>Aims</h4>To explore patterns of and associations between use of psychotropic, gastrointestinal and analgesic medications and eating disorders in the period before, during and after pregnancy.<h4>Method</h4>This study is based on the Norwegian Mother and Child Cohort Study (MoBa). A total of 62,019 women, enrolled at approximately 17 weeks' gestation, had valid data from the Norwegian Medical Birth Registry and completed three MoBa questionnaires. The questionnaires provided diagnostic information on broadly defined anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED) and recurrent self-induced purging in the absence of binge eating (EDNOS-P), along with self-reported use of medication six months before, during, and 0-6 months after pregnancy.<h4>Results</h4>The prevalence of eating disorder subtypes before and/or during pregnancy was: 0.09% AN (n = 54), 0.94% BN (n = 585), 0.10% EDNOS-P (n = 61) and 5.00% BED (n = 3104). The highest over-time prevalence of psychotropic use was within the AN (3.7-22.2%) and EDNOS-P (3.3-9.8%) groups. Compared to controls, BN was directly associated with incident use of psychotropics in pregnancy (adjusted RR: 2.25, 99% CI: 1.17-4.32). Having AN (adjusted RR: 5.11, 99% CI: 1.53-17.01) or EDNOS-P (adjusted RR: 6.77, 99% CI: 1.41-32.53) was directly associated with use of anxiolytics/sedatives postpartum. The estimates of use of analgesics (BED) and laxatives (all eating disorders subtypes) were high at all time periods investigated.<h4>Conclusions</h4>Use of psychotropic, gastrointestinal, and analgesic medications is extensive among women with eating disorders in the period around pregnancy. Female patients with eating disorders should receive evidence-based counseling about the risk of medication exposure versus the risk of untreated psychiatric illness during pregnancy and postpartum.https://doi.org/10.1371/journal.pone.0133045
spellingShingle Angela Lupattelli
Olav Spigset
Leila Torgersen
Stephanie Zerwas
Marianne Hatle
Ted Reichborn-Kjennerud
Cynthia M Bulik
Hedvig Nordeng
Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.
PLoS ONE
title Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.
title_full Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.
title_fullStr Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.
title_full_unstemmed Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.
title_short Medication Use before, during, and after Pregnancy among Women with Eating Disorders: A Study from the Norwegian Mother and Child Cohort Study.
title_sort medication use before during and after pregnancy among women with eating disorders a study from the norwegian mother and child cohort study
url https://doi.org/10.1371/journal.pone.0133045
work_keys_str_mv AT angelalupattelli medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy
AT olavspigset medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy
AT leilatorgersen medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy
AT stephaniezerwas medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy
AT mariannehatle medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy
AT tedreichbornkjennerud medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy
AT cynthiambulik medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy
AT hedvignordeng medicationusebeforeduringandafterpregnancyamongwomenwitheatingdisordersastudyfromthenorwegianmotherandchildcohortstudy